Conestoga Capital Advisors, LLC Amgen Inc Transaction History

Conestoga Capital Advisors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 Apr 21, 2023	SELL	$225.79 - $275.2 $45,158 - $55,040	-200 Reduced 15.04%	1,130 $273,000
Q3 2017 Oct 20, 2017	BUY	$167.29 - $191.0 $222,495 - $254,030	1,330	1,330 $248,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.